221 related articles for article (PubMed ID: 25795717)
21. Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
Campbell HE; Estcourt LJ; Stokes EA; Llewelyn CA; Murphy MF; Wood EM; Stanworth SJ;
Transfusion; 2014 Oct; 54(10):2394-403. PubMed ID: 24826894
[TBL] [Abstract][Full Text] [Related]
22. Platelet transfusions for patients with haematological malignancies: who needs them?
Estcourt LJ; Stanworth SJ; Murphy MF
Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
[TBL] [Abstract][Full Text] [Related]
23. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
Diedrich B; Remberger M; Shanwell A; Svahn BM; Ringdén O
Transfusion; 2005 Jul; 45(7):1064-72. PubMed ID: 15987349
[TBL] [Abstract][Full Text] [Related]
24. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
[TBL] [Abstract][Full Text] [Related]
25. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
[TBL] [Abstract][Full Text] [Related]
26. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
Callow CR; Swindell R; Randall W; Chopra R
Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
[TBL] [Abstract][Full Text] [Related]
27. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.
Webert K; Cook RJ; Sigouin CS; Rebulla P; Heddle NM
Haematologica; 2006 Nov; 91(11):1530-7. PubMed ID: 17043016
[TBL] [Abstract][Full Text] [Related]
28. Compliance with prophylactic platelet transfusion trigger in haematological patients.
Eikenboom JC; van Wordragen R; Brand A
Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
[TBL] [Abstract][Full Text] [Related]
29. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
31. Benefits of Thromboelastography and Thrombin Generation Assay for Bleeding Prediction in Patients With Thrombocytopenia or Hematologic Malignancies.
Kim SY; Gu JY; Yoo HJ; Kim JE; Jang S; Choe S; Koh Y; Kim I; Kim HK
Ann Lab Med; 2017 Nov; 37(6):484-493. PubMed ID: 28840985
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia and bleeding in pediatric oncology patients.
Bercovitz RS; Josephson CD
Hematology Am Soc Hematol Educ Program; 2012; 2012():499-505. PubMed ID: 23233625
[TBL] [Abstract][Full Text] [Related]
33. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
34. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
35. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
36. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions.
Friedmann AM; Sengul H; Lehmann H; Schwartz C; Goodman S
Transfus Med Rev; 2002 Jan; 16(1):34-45. PubMed ID: 11788928
[TBL] [Abstract][Full Text] [Related]
37. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers.
Fanning J; Hilgers RD; Murray KP; Bolt K; Aughenbaugh DM
Gynecol Oncol; 1995 Nov; 59(2):191-3. PubMed ID: 7590471
[TBL] [Abstract][Full Text] [Related]
38. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.
Han TT; Xu LP; Liu DH; Liu KY; Wang FR; Wang Y; Yan CH; Chen YH; Sun YQ; Ji Y; Wang JZ; Zhang XH; Huang XJ
Ann Hematol; 2015 Jan; 94(1):117-28. PubMed ID: 25069650
[TBL] [Abstract][Full Text] [Related]
40. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
